Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-04-09 5:09 pm Sale | 13G | VINCERX PHARMA, INC VINC | GOLDMAN SACHS GROUP INC GS | 631,490 3% | -1,078,166 (-63.06%) | View |
2024-03-11 4:36 pm Purchase | 13G | MORPHOSYS AG SPONSORED ADS MOR | GOLDMAN SACHS GROUP INC GS | 4,141,089 10.8% | 4,141,089 (New Position) | View |
2024-03-05 4:52 pm Sale | 13G | DWAVE QUANTUM INC QBTS | GOLDMAN SACHS GROUP INC GS | 2,140,091 1.9% | -5,799,324 (-73.04%) | View |
2024-02-16 4:34 pm Unchanged | 13G | DWAVE QUANTUM INC QBTS | GOLDMAN SACHS GROUP INC GS | 7,939,415 7% | 0 (Unchanged) | View |
2024-02-14 12:21 pm Sale | 13G | DWAVE QUANTUM INC QBTS | GOLDMAN SACHS GROUP INC GS | 7,939,415 5% | -1,367,438 (-14.69%) | View |
2024-02-13 6:03 pm Sale | 13G | STERLING CHECK CORP COM STER | GOLDMAN SACHS GROUP INC GS | 49,809,136 52.8% | -10,147,384 (-16.92%) | View |
2024-02-13 5:35 pm Sale | 13G | GOLDMAN SACHS BDC INC SHS GSBD | GOLDMAN SACHS GROUP INC GS | 6,511,381 5.9% | -332 (-0.01%) | View |
2024-02-13 4:55 pm Sale | 13G | GOLDMAN SACHS GROUP INC GS | VANGUARD GROUP INC | 28,546,582 8.75% | -978,128 (-3.31%) | View |
2024-02-13 3:57 pm Sale | 13G | SPRING VY ACQUISITION CORP II SVII | GOLDMAN SACHS GROUP INC GS | 722,419 3.1% | -526,372 (-42.15%) | View |
2024-02-13 3:49 pm Purchase | 13G | PERFECT CORP PERF | GOLDMAN SACHS GROUP INC GS | 11,079,576 10.9% | 2,274,879 (+25.84%) | View |
2024-02-13 3:21 pm Sale | 13G | INNOVID CORP COM CTV | GOLDMAN SACHS GROUP INC GS | 189,382 0.1% | -8,391,855 (-97.79%) | View |
2024-02-13 3:02 pm Purchase | 13G | BRILLIANT ACQUISITION CORP BRLI | GOLDMAN SACHS GROUP INC GS | 140,445 7.2% | 140,445 (New Position) | View |
2024-02-13 3:00 pm Purchase | 13G | MIDDLEBY CORP MIDD | GOLDMAN SACHS GROUP INC GS | 531,229 1% | 531,229 (New Position) | View |
2024-02-13 11:42 am Sale | 13G | PRIVIA HEALTH GROUP INC PRVA | GOLDMAN SACHS GROUP INC GS | 41,373 0% | -24,783,287 (-99.83%) | View |
2024-02-13 10:42 am Sale | 13G | ELDORADO GOLD CORP COM EGO | GOLDMAN SACHS GROUP INC GS | 9,649,321 4.7% | -1,350,639 (-12.28%) | View |
2024-02-13 10:27 am Sale | 13G | ZIMVIE INC ZIMV | GOLDMAN SACHS GROUP INC GS | 87,588 0.3% | -1,763,310 (-95.27%) | View |
2024-02-12 7:42 pm Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | GOLDMAN SACHS GROUP INC GS | 1,181,931 6.8% | 1,181,931 (New Position) | View |
2024-02-12 7:40 pm Sale | 13G | CSLM ACQUISITION CORP. CLASS A CSLM | GOLDMAN SACHS GROUP INC GS | 220 0% | -1,018,731 (-99.98%) | View |
2024-02-12 6:53 pm Purchase | 13G | WINNEBAGO INDS INC WGO | GOLDMAN SACHS GROUP INC GS | 1,756,336 6% | 1,756,336 (New Position) | View |
2024-02-12 6:15 pm Sale | 13G | SILENCE THERAPEUTICS PLC SPONS SLN | GOLDMAN SACHS GROUP INC GS | 2,316,169 2.2% | -2,224,994 (-49.00%) | View |